Get To Know: Linnea Brings Decades Of Drug Ingredient Experience To Pharma Cannabinoids

Swiss firm anticipates potential to enhance patient outcomes, reduce side effects and increase efficacy of cannabinoid-based treatments while answering unmet demand for cosmetic and skin-care products containing non-psychoactive cannabinoids.